✦ LIBER ✦

P.3.c.064 Interventions in antipsychotics-treated patients with cardiometabolic risk factors or metabolic syndrome

✍ Scribed by J. Larsen; M. Holdrup; B. Christensen; C. Sigalin; P.M. Nilsson; S. Kolb

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.b.038 Prevalence of metabolic syndro

✍ Ferreiro Fernandez, B.; García Mahía, M.C.; Vidal Millares, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P.3.c.027 Metabolic syndrome, cardiovasc

✍ J. Castaño; B. Diaz; C. Garnier; R. Sanchis; A. Horta; A. Navarro; R. Navines; L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

P.3.c.049 Risk of adverse health outcome

✍ J. Merchán-Naranjo; M. Giráldez-Quiroga; C. Moreno; L. Pina; M. Parellada; C. Ta 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 76 KB

P.3.a.026 Ziprasidone switching effects

✍ R. Grigorescu; V. Voicu; D. Vasile; G. Grigorescu; M. Staicu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

P.3.f.007 Association between metabolic

✍ Vataire, A.; Ferchichi, S.; Desroziers, K.; Cadi-Soussi, N.; Murthy, V.; Toumi, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P.3.132 High prevalence of metabolic ris

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 240 KB